23rd week of 2009 patent applcation highlights part 33 |
Patent application number | Title | Published |
20090142206 | HYDRAULIC CIRCUIT OF A SERVO-ASSISTED MECHANICAL TRANSMISSION - A hydraulic circuit of a servo-assisted mechanical transmission, which is provided with a number of hydraulic actuators provided with corresponding actuation chambers adapted to be filled with pressurized oil; the hydraulic circuit is provided with: a number of solenoid valves, each of which is coupled to a corresponding actuation chamber of a hydraulic actuator; a tank, which contains the oil at atmospheric pressure and is provided with an upper loading aperture; the cap, which closes the loading aperture of the tank and is provided with a through venting hole which puts the tank into communication with the external environment; a filtering element, which is coupled to the cap and is arranged under the venting hole; a hydraulic accumulator containing the pressurized oil; and an electric pump which draws from the tank and feeds the hydraulic accumulator. | 2009-06-04 |
20090142207 | BOTTOM HOLE HOLLOW CORE ELECTRIC SUBMERSIBLE PUMPING SYSTEM - An electric submersible pumping system includes a motor comprising an inner hollow core rotor and an outer stator, a gearbox comprising a hollow core input shaft connected to the motor rotor, and a hollow core output shaft, and a pump driven by the gearbox output shaft, the pump having an intake, and wherein the pump output is directed through the hollow core output shaft and into the hollow core motor rotor. The motor section is disposed above the gearbox and pump. | 2009-06-04 |
20090142208 | MOTOR AND PUMP ASSEMBLY HAVING IMPROVED SEALING CHARACTERISTICS - The present invention comprehends a gerotor or gear pump driven by a permanent magnet motor which exhibits cogging torque, i.e., resistance to rotation when de-energized caused by interaction between permanent magnets in the rotor and teeth on the stator. Such interaction causes the rotor to come to rest in one of many defined rotational positions and resist rotation when electrical power to the motor has been terminated. The permanent magnet motor is coupled, preferably directly, to a gerotor pump having meshing rotors or a gear pump having meshing gears. When the motor is de-energized, the pump rotors or gears come to rest and their rotation is resisted by the cogging torque of the motor. The invention finds particular application in automotive transmissions and systems with parallel pumps. | 2009-06-04 |
20090142209 | Piezoelectric Pump - A piezoelectric pump capable of generating a large displacement at a central portion of a piezoelectric element even when a driving voltage is relatively low and preventing short-circuits caused by migration. The piezoelectric pump includes a pump body with a pump chamber, and a piezoelectric element that closes the pump chamber. The central area and the peripheral area of the piezoelectric element are bent in opposite directions by applying voltages to the piezoelectric element so that the volume of the pump chamber is changed. The piezoelectric element is a laminate including a plurality of piezoelectric layers with electrodes interposed therebetween. The central area and the peripheral area of each piezoelectric layer are polarized opposite to each other in the thickness direction, and the electrodes are formed such that voltages in the same direction in the thickness direction are applied to the central area and the peripheral area of each piezoelectric layer. Since voltages at the same potential are applied to the electrodes formed in the same planes of the piezoelectric layers, short-circuits caused by migration can be prevented. | 2009-06-04 |
20090142210 | Suction structure in piston type compressor - A suction structure allows refrigerant from a suction pressure region in a piston type compressor. The suction structure includes a shifting device, a bleed passage, and a check valve. The shifting device has a valve body, a return spring, a backpressure chamber, and a backpressure passage. The valve body is movable between a connecting position and a disconnecting position. The return spring urges the valve body from the connecting position toward the disconnecting position. The backpressure chamber is defined by the valve body. The backpressure passage communicates with the suction pressure region and the backpressure chamber. The bleed passage communicates with the suction pressure region and the backpressure chamber. The check valve allows a fluid to flow from the backpressure chamber into the bleed passage. | 2009-06-04 |
20090142211 | ROTARY STEAM ENGINE - A circular, reversible steam powered engine configured to force pistons mounted in circular housing assembly and coupled to a main shaft to create a work load. The steam powered engine is arranged to pipe steam of a high pressure into steam chambers to force pistons forward and push exhaust steam of a low pressure out of steam chambers. Gears rotate and engage with pistons to start and stop steam flow into timing valves and steam flow portions. The engine creates a torque required to effectively operate many types of loads, such as those for vehicle and equipment applications. | 2009-06-04 |
20090142212 | Rotary blower with noise abatement jacket enclosure - A rotary blower with noise abatement jacket enclosure having multiple interconnected and synchronized parallel multi-lobe rotors with the same number of lobes for propelling flow from a suction port to a discharge port of an inner casing without internal compression. The noise abatement jacket enclosure is shaped to surround the blower and to conform generally to its body contours, but is oversized to provide adequate cooling spaces with outer skin of the blower. It comprises a forced air cooling jacket comprising an inner and outer cover, a sound absorbent layer comprising an inner and outer surface, the inner surface in contact with the blower outer cooling cover, and a sound barrier layer comprising an inner surface in contact with the outer surface of the sound absorbent layer. | 2009-06-04 |
20090142213 | ROOTS-TYPE BLOWER REDUCED ACOUSTIC SIGNATURE METHOD AND APPARATUS - A Roots-type blower with helical cycloidal rotors features relief recesses in the chamber walls, isolated from the input and output ports. The relief recesses counter variation in leakback flow with angular position intrinsic to helical cycloidal rotors, attenuating a noise source. | 2009-06-04 |
20090142214 | ROTARY COMPRESSOR - In a compression mechanism of a rotary compressor, a cylinder chamber is defined by a cylinder and a second housing. A back surface side gap is defined between an end plate part of the cylinder and a flat plate part of a first housing. The first housing is provided with a communicating path and a differential pressure regulating valve. When the difference between the suction pressure and the discharge pressure is small, the discharge pressure is introduced through the communicating path to an intermediate gap whereby both an internal gap and the intermediate gap are placed at the same pressure as the discharge pressure. Conversely, when the difference between the discharge pressure and the suction pressure is great, the communicating path is made discontinuous by the differential pressure regulating valve whereby the intermediate gap is placed at an intermediate pressure lower than the discharge pressure. | 2009-06-04 |
20090142215 | Vane Pump with Tilting Pad Radial Bearings - A vane pump comprises: a drive shaft that passes through the pump frame; a rotor coupled to the drive shaft that has multiple vanes and rotates within the pump frame in an axial direction about an axis of rotation with an outer rotor surface that has a radius that extends from the axis of rotation; a cam ring within the pump frame that circumscribes the rotor and vanes with a cam ring inner surface; multiple radial tilting pad bearings that support the cam ring; a bearing support ring coupled to the pump frame that generally circumscribes the cam ring and mounts the radial tilting pad bearings; side plates that radially extend from the drive shaft to the pump frame to enclose the rotor and the cam ring with at least one side plate having an inlet port and an outlet port; and means for initiating rotation of the cam ring from rest. | 2009-06-04 |
20090142216 | FIXED VANE TYPE HYDRAULIC MOTOR - Disclosed is a fixed vane type hydraulic motor in which a steady output can be obtained and rotation speed of an output shaft can be varied. The hydraulic motor includes a main body having an actuating space provided therein, a fluid passing device to make the fluid flow toward the main body and a horizontal rotation body, a fluid compulsorily circulating device to compulsorily circulate the fluid through the respective fluid chambers, and an oblique rotation body having a rotation plate which is rotatably mounted to the opened opposite side of the main body and to the horizontal rotation body by a fixing device. | 2009-06-04 |
20090142217 | COMPOSITION AND METHOD - A method includes contacting a transition metal oxide, a sintering additive, and a grain growth inhibitor additive to form a mixture. The transition metal oxide include particles that have an average diameter less than about 1 micrometer and treating the mixture to a temperature profile that is sufficiently high that a sintered mass is formed from the mixture. The thermal profile is less than about 1050 degrees Celsius. | 2009-06-04 |
20090142218 | LEAN AUSTENITIC STAINLESS STEEL - An austenitic stainless steel having low nickel and molybdenum and exhibiting comparable corrosion resistance and formability properties to higher nickel and molybdenum alloys comprises, in weight %, up to 0.20 C, 2.0-9.0 Mn, up to 2.0 Si, 16.0-23.0 Cr, 1.0-5.0 Ni, up to 3.0 Mo, up to 3.0 Cu, 0.1-0.35 N, up to 4.0 W, up to 0.01 B, up to 1.0 Co, iron and impurities, the steel having a ferrite number of less than 10 and a MD | 2009-06-04 |
20090142219 | SINTER-HARDENING POWDER AND THEIR SINTERED COMPACTS - A sinter-hardening powder can yield a sintered compact with high strength, high hardness, and high density. A raw powder for sintering includes Fe as its primary component and also comprising 0.1-0.8 wt % C, 5.0-12.0 wt % Ni, 0.1-2.0 wt % Cr, and 0.1-2.0 wt % Mo, wherein the mean particle size of the raw powder for sintering is 20 μm or less. The sintered and tempered compact, without any quenching treatment, has high hardness, high strength, high density, and good ductility. | 2009-06-04 |
20090142220 | SINTER-HARDENING POWDER AND THEIR SINTERED COMPACTS - A sinter-hardening raw powder can yield a press-and-sinter compact with high hardness. The raw powder for sintering includes Fe as its primary component and also includes 0.3-0.8 wt % C, 5.0-12.0 wt % Ni, 1.0-5.0 wt % Cr, and 0.1-2.0 wt % Mo, wherein the mean particle size of the raw powder for sintering is between 50 and 100 μm. The sintered and tempered compact, without any quenching treatment, has high hardness. | 2009-06-04 |
20090142221 | ENGINE COMPONENTS AND METHODS OF FORMING ENGINE COMPONENTS - Engine components that include a compacted powder material comprising a nickel-based superalloy having less than five parts per million sulfur, by weight and methods of forming the components are provided. In an embodiment, by way of example only, a method includes flowing a gas into a can with a metal powder therein, the gas comprising hydrogen, the can configured to be used for a consolidation process, and the superalloy comprising sulfur. Gas is flowed into and then removed from the can. A sulfur content of the removed gas is determined during the process. The can and the metal powder therein are subjected to the consolidation process, if a determination is made that the sulfur content of the metal powder is below a threshold value, the threshold value being a value below about 1 part per million by weight. | 2009-06-04 |
20090142222 | ALUMINUM-COPPER-LITHIUM ALLOYS - Improved aluminum-copper-lithium alloys are disclosed. The alloys may include 3.4-4.2 wt. % Cu, 0.9-1.4 wt. % Li, 0.3-0.7 wt. % Ag, 0.1-0.6 wt. % Mg, 0.2-0.8 wt. % Zn, 0.1-0.6 wt. % Mn, and 0.01-0.6 wt. % of at least one grain structure control element, the balance being aluminum and incidental elements and impurities. The alloys achieve an improved combination of properties over prior art alloys. | 2009-06-04 |
20090142223 | Sterilization of consumable composition dispensers - Methods and systems for programmed dispensation of consumable compositions are provided. | 2009-06-04 |
20090142224 | High Surface Area Material Blends for Odor Reduction, Articles Utilizing Such Blends and Methods of Using Same - A method for neutralizing odor contained within the headspace of product packaging includes the steps of formulating a blend of either modified and unmodified high surface area materials, differently modified high surface area materials, different unmodified high surface area materials, or a combination thereof; applying the blend of high surface area materials to the inside of the product packaging. | 2009-06-04 |
20090142225 | Ice Bins, Ice Makers, and Methods for Cleaning Ice Bins and Ice Makers - An ice maker includes an ozone generator that has a housing having an air inlet and an air outlet functionally connected to the air inlet for allowing air to flow through the housing. The ozone generator further includes an ozone generating device in the housing. The air outlet is functionally connected to a thermally insulated interior of the ice bin for feeding air containing ozone from ozone generator to the thermally insulated interior, and the air inlet of the ozone generator is functionally connected to the thermally insulated interior of the ice bin for receiving air from the thermally insulated interior. Ice bins and methods for cleaning an ice bin and an ice maker are also described. | 2009-06-04 |
20090142226 | USE OF STORAGE-STABLE AQUEOUS SOLUTIONS OF CHLORINE DIOXIDE TO GENERATE PURE CHLORINE DIOXIDE GAS FOR DECONTAMINATION - New compositions and methods are disclosed for decontaminating surfaces and enclosures that avoid problems such as salt deposits, corrosion and condensation that accompany the use of known methods. The process involves the use of chlorine dioxide solutions prepared by passing dilute chlorine gas over solid granular sodium chlorite to produce chlorine dioxide gas which is then collected in solution. The chlorine dioxide gas can be introduced into an enclosure and used to disinfect a portion of the contents of the enclosure. | 2009-06-04 |
20090142227 | Parylene Coating and Method for the Production Thereof - In a method for producing a parylene coating on a substrate containing an integrated electronic component which is e.g. an x-ray detector, the following steps are provided: vaporization of parylene; pyrolyzation of the vaporized parylene; polymerization of the pyrolyzed parylene, the polymerized parylene being deposited on a cooled substrate. The method provides controllable, patterned deposition of parylene on the cooled and/or heated substrate, the advantage being that x-ray converters, for example, can be anticorrosively encapsulated and a penetration depth of the parylene between phosphor needles or storage phosphor needles can be controlled, resulting in an improved resolution and improved modulation transfer function of electronic components. | 2009-06-04 |
20090142228 | PRODUCTION WASTE TEST KIT - A test kit for testing production waste includes a plurality of components including reagents, test equipment, or a combination thereof, sufficient to perform analysis on production waste and at least one protective case for shipping and for using the plurality of components, the protective case including a top portion releasably engaged with a bottom portion. The top portion includes a top side attached at an inner face of the top side to a top edge of a continuous sidewall formed by a plurality of sides such that the top portion of the protective case includes a hollow interior cavity bound by the inner face of the top side and an inner face of the continuous sidewall, wherein the hollow interior cavity is open on a bottom side, and wherein the hollow interior cavity defines a water-tight enclosure opened on the bottom side, such that the top portion, resting on a support surface inverted on an outer face of the top side, is capable of forming a liquid reservoir. | 2009-06-04 |
20090142229 | Blood Cell Barrier for a Lateral Flow Device - A lateral flow device for analyzing a whole blood sample is provided. More specifically, the lateral flow device contains a porous membrane that defines a barrier zone for separating red blood cells from blood plasma (includes plasma in which clotting factors haven been removed), which may then flow to a subsequent detection zone for analysis. The barrier zone is formed from a blood cell barrier composition that includes an unsaturated aliphatic fatty acid or an ester thereof. Without intending to be limited by theory, the present inventors believe such unsaturated aliphatic fatty acid molecules undergo autoxidation in the presence of air and hemoglobin to release peroxides (e.g., hydrogen peroxide) via oxidative saturation of double bonds. In turn, the released peroxides are believed to induce the formation of echinocytes or crenated blood cells. The crenated red blood cells are distorted in shape and less flexible and malleable than normal red blood cells, making them less able to penetrate into the pores of the porous membrane of the lateral flow device. Consequently, the stiffer, less flexible cells cannot move easily into the porous and become trapped at the surface of the membrane, while the liquid components of the sample flow and penetrate through the membrane to the detection zone for analysis. | 2009-06-04 |
20090142230 | ASSEMBLY COMPRISING J AGGREGATES - The present invention relates to the realization of particular supramolecular assemblies of dyes, in particular cyanines, called J aggregates. The invention concerns an assembly made up of
| 2009-06-04 |
20090142231 | AUTOMATIC ANALYZER - The automatic analyzer stores: a predetermined period from the opening of a reagent vessel to the deterioration of the reagent; a reagent production lot number, reagent vessel unsealing time, and reagent expiration date as reagent information kept on a reagent-set-by-set basis; and relevant calibration curve factor information. The automatic analyzer judges whether a calibration curve factor for a reagent set is applicable or not to another reagent set of the analyzer with the same production number based on the predetermined period from the reagent vessel unsealing time and on the reagent expiration date. | 2009-06-04 |
20090142232 | MICROCHIP - The present invention provides a microchip which is made by bonding a first substrate having a groove provided at the substrate surface and a second substrate together, and has a fluid circuit therein, the fluid circuit having a separation portion for separating a first component, and a groove which constitutes the separation portion including an approximately V-shaped region surrounded by prescribed flow channel walls. At a top of the separation portion, a flow rate limiting portion limiting a flow rate of a fluid is preferably provided. | 2009-06-04 |
20090142233 | Gas sensor system - A system including a sensor and a sensor holder. The sensor includes an inlet port for receiving a gas sample and an outlet port for exhausting a portion of the gas sample. The sensor generates an output signal indicative of an oxygen concentration of the gas sample. The sensor holder removably receives and contains the sensor and includes an inlet port for communicating the gas sample to the sensor and an outlet port for receiving the exhausted portion of the gas sample from the sensor. The inlet port of the sensor holder is aligned and sealably interfaced with the inlet port of the sensor such that the inlet ports defining a common inlet bore. The outlet port of the sensor holder is aligned and sealably interfaced with the outlet port of the sensor such that the outlet ports defining a common outlet bore. | 2009-06-04 |
20090142234 | Multi-element structured arrays (MESA's) for cost effective and high efficiency treatment of fluids - Multi-Element Structured Arrays (MESAs) present an effective approach to utilizing high pressure drop media that previously were cost prohibitive for use in a traditional filter element. The operational velocity is significantly slowed by the incorporation of numerous elements; thus, eliminating the Darcian flow resistances of the media. The MESAs are readily fitted with two or more replaceable “filter elements” that are able to employ commercially available media, microfibrous entrapped catalyst/sorbent media, unique multilayers and more. A model capable of estimating pressure drop for flow through a pleated filter is able to be used as a design tool to predict minimum initial pressure drop, maximum filtration area, and preferred media properties with respect to permeability versus thickness thus allowing the filtration system's dirt holding capacity, filtration efficiency and operational energy cost and filtration operational and total ownership costs such as blower energy, filter procurement and shipping, maintenance personnel, filter disposal, inventory and storage, cost of money and more to be improved. | 2009-06-04 |
20090142235 | SYSTEMS AND METHODS FOR PRODUCING AQUEOUS SOLUTIONS AND GASES HAVING DISINFECTING PROPERTIES AND SUBSTANTIALLY ELIMINATING IMPURITIES - A system for disinfecting and purifying aqueous solutions and water for drinking purposes comprising an outer pouch, a disinfectant generating device, and an inorganic coagulant. The disinfectant generating device is provided with a membrane shell defining at least two compartments which house a first reactant, a second reactant, and an inorganic coagulant. The disinfectant generating device is capable of producing a disinfectant when exposed to water or moisture and the disinfectant exits the compartment through the membrane shell. The inorganic coagulant aid the formation of flocs of the suspended dispersed particles in the aqueous solution. | 2009-06-04 |
20090142236 | Microfluidic Devices and Methods of Using Same - An M.times.N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block. | 2009-06-04 |
20090142237 | Micro reactor - The present invention discloses the substrate and the micro reactor for mixing two kinds of fluids. The micro reactor of the present invention comprises a housing having first and second inlet ports and an outlet port formed thereon; and a plurality of substrates stacked in the housing, wherein the substrate has a space formed at a central portion thereof in one direction; a plurality of first channels extended from one side thereof to the space and corresponding to the first inlet port; and a plurality of second channels extended from the other side thereof to the space and corresponding to the second inlet port; wherein a portion between two neighboring first channels corresponds to the second channel and a portion between two neighboring second channels corresponds to the first channel to form sequentially reaction interfaces of the first and second fluids in the space. | 2009-06-04 |
20090142238 | APPARATUS FOR INCINERATING GASES FROM A PROCESSING CHAMBER - An oven for baking a batch of parts has a housing having side walls and a top wall defining a closed container with a closed top end and an open downwardly facing bottom end. Loading/unloading occurs at the bottom end onto a carriage raised to the top end where baking occurs. On each side is provided an array of heating elements below the top. A shield is located in front of the heating array so as to block direct radiation onto the parts to prevent over-heating as the carrying arrangement passes the heating array to be unloaded. The shield generates an upwardly flowing air stream to carry the heat to the top. The heating elements are mounted with their lower end in a connection box with a collar and insulated heat shield above the box to keep the electrical connections cooled. | 2009-06-04 |
20090142239 | Exhaust purification apparatus of internal combustion engine - An exhaust purification apparatus of an internal combustion engine purifying exhaust gas by removing SOx from the exhaust gas is provided. In the exhaust purification apparatus provided with sulfur oxide trapping material for trapping sulfur oxides exhausted from an internal combustion engine, aggregates of the sulfur oxide trapping material ( | 2009-06-04 |
20090142240 | Catalyst Containment Design for Radial Flow Reactors - An apparatus is presented for contacting a bed of particulate material with a cross flowing fluid, which maintains the bed of particulate material within a retention volume. The apparatus includes partitions for retaining particles, with openings disposed within the partitions. The openings are covered by louvers that extend above the edges of the openings to prevent solid particles from spilling through inlet openings, and the design prevents the loss of particles through the openings during cooldown of the apparatus. | 2009-06-04 |
20090142241 | SYSTEM AND PROCESS FOR THE SEPARATION OF SUSPENSIONS OF SPENT CATALYSTS AND HYDROCARBONS FORMED IN A FLUID CATALYTIC CRACKING UNIT WITH MULTIPLE ASCENDING FLOW REACTION TUBES - The present invention relates to a system for the separation of suspensions of spent catalysts and hydrocarbons formed in an FCC unit with multiple ascending flow reaction tubes, comprising interconnections between each of the ascending flow reaction tubes and the separator vessel, each interconnection also comprises two sections The outside sections of the separator vessel are inclined and are connected to a single vertical section, which penetrates into the interior of the separator vessel, and which has at its lower end an open device for draining the spent catalyst from the suspensions separated in this sector. In the same vertical section, at the end of its internal part at the separator vessel, a series of two sets of cyclones are installed, the first set containing cyclones without sealing legs, and the second set containing conventional cyclones of the first stage. | 2009-06-04 |
20090142242 | Vanadium/Titania Catalyst Comprising Natural Manganese Ore for Removing Nitrogen Oxides and Dioxin in Wide Operating Temperature Range and Method of Using the Same - Disclosed is a vanadium/titania-based catalyst including natural manganese ore for removing nitrogen oxides and dioxin in a wide operating temperature range and a method of using the same. Specifically, this invention pertains to a vanadium/titania (V/TiO2)-based catalyst including natural manganese ore for removing nitrogen oxides and dioxin in a wide operating temperature range, in which the WTiO2 catalyst for selective catalytic reduction of nitrogen oxides and removal of dioxin contained in flue gas includes 5-30 wt % of natural manganese ore, thus exhibiting excellent activity of removing nitrogen oxides even in the low temperature range and of removing dioxin at the same time, and to a method of using the same. The catalyst of this invention has good thermal stability and thus can simultaneously manifest nitrogen oxides removal performance and dioxin removal performance superior to conventional vanadium/titania catalysts in a wide temperature range (150˜450° C.) including not only a high temperature range but also a low temperature range. As well, since unreacted ammonia emissions can be reduced, the formation of an ammonium salt is prevented and ammonium nitrate is decomposed at low temperatures, thus solving the problems of inactivation of the catalyst due to catalytic poisoning and of a shortened lifetime thereof, leading to economic benefits. | 2009-06-04 |
20090142243 | Methods and systems for reducing the emissions from combustion gases - A method for reducing the emissions from combustion gases produced during a combustion process includes injecting a hydrocarbon-based reducing agent into the combustion gases to form a combustion gas mixture. The combustion gas mixture including oxides of nitrogen, NO | 2009-06-04 |
20090142244 | TREATMENT METHOD FOR DECOMPOSING PERFLUOROCOMPOUND, DECOMPOSING CATALYST AND TREATMENT APPARATUS - An object of the present invention is to improve the decomposition at low temperatures of perfluorocompounds containing only fluorine as a halogen, such as CF | 2009-06-04 |
20090142245 | Method of producing nanophosphor particles - Provided is a method of producing spherical nanophosphor particles having a uniform size distribution. When nanophosphor obtained using the method is used in a flat panel display, the flat panel display has higher screen brightness and a higher resolution. | 2009-06-04 |
20090142246 | Method for separating and recovering conversion reaction gas - Provided is a method for separating and recovering conversion reaction gas, wherein after a conversion reaction process for producing trichlorosilane from hydrogen gas and silicon tetrachloride comprising; condensing step of cooling discharged gas, separating step of silicon tetrachloride from the condensed liquid, and recovering disilicon hexachloride. For example, the method includes a first distillation process for distilling trichlorosilane from the condensed liquid, a second distillation process for distilling silicon tetrachloride from residual liquid of the first distillation process, and a third distillation process for distilling disilicon hexachloride from residual liquid of the second distillation process. | 2009-06-04 |
20090142247 | Chemical treatment to reduce machining-induced sub-surface damage in semiconductor processing components comprising silicon carbide - Method of removing damaged silicon carbide crystalline structure from the surface of a silicon carbide component. The method comprises at least two liquid chemical treatment processes, where one treatment converts silicon carbide to silicon oxide, and another treatment removes silicon oxide. The liquid chemical treatments are typically carried out at a temperature below about 100° C. The time period required to carry out the method is generally less than about 100 hours. | 2009-06-04 |
20090142248 | Method For Purifying Nitrogen Trifluoride - A highly pure nitrogen trifluoride having a carbon tetrafluoride content of 10 ppm or less can be effectively obtained by boiling crude liquid nitrogen trifluoride having carbon tetrafluoride contaminant under a pressure ranging from 35 to 45 atm, to remove carbon tetrafluoride therefrom through vaporization. | 2009-06-04 |
20090142249 | DIAMOND SINGLE CRYSTAL SUBSTRATE - A method for manufacturing a diamond single crystal substrate, in which a single crystal is grown from a diamond single crystal serving as a seed substrate by vapor phase synthesis, said method comprising: preparing a diamond single crystal seed substrate which has a main surface whose planar orientation falls within an inclination range of not more than 8 degrees relative to a {100} plane or a {111} plane, as a seed substrate; forming a plurality of planes of different orientation which are inclined in the outer peripheral direction of the main surface relative to the main surface on one side of this seed substrate, by machining; and then growing a diamond single crystal by vapor phase synthesis. | 2009-06-04 |
20090142250 | DEVICE AND METHOD FOR CONVERTING CARBON CONTAINING FEEDSTOCK INTO CARBON CONTAINING MATERIALS HAVING A DEFINED NANOSTRUCTURE - Apparatus and process for producing carbon black or carbon containing compounds by converting a carbon containing feedstock, comprising the following steps: generating a plasma gas with electrical energy, guiding the plasma gas through a venturi, whose diameter is narrowing in the direction of the plasma gas flow, guiding the plasma gas into a reaction area, in which under the prevailing flow conditions generated by aerodynamic and electromagnetic forces, no significant recirculation of feedstock into the plasma gas in the reaction area recovering the reaction products from the reaction area and separating carbon black or carbon containing compounds from the other reaction products. | 2009-06-04 |
20090142251 | METHOD FOR TREATING CARBON NANOTUBES, CARBON NANOTUBES AND CARBON NANOTUBE DEVICES - A method for treating carbon nanotubes is provided. In the method for treating carbon nanotubes (CNTs), the CNTs are treated with SO | 2009-06-04 |
20090142252 | METHOD AND SYSTEM FOR PRODUCING ACTIVATED CARBON - An activated carbon producing system includes a carbonizer for carbonizing cellulose triacetate as cellulose acylate to create carbonized material. A pulverizer pulverizes the carbonized material to obtain granules. An activation device activates the granules to create activated carbon. The activated carbon producing system includes a dispenser for supplying the cellulose triacetate at a plural number of times. A heating furnace is operated at each time after the dispenser operates, for thermally decomposing the cellulose triacetate from the dispenser, to obtain the carbonized material by carbonization. The pulverizer pulverizes the carbonized material in a size equal to or more than 2 mm and equal to or less than 20 mm. Temperature of the heating furnace is equal to or higher than 300 deg. C. and equal to or lower than 600 deg. C. | 2009-06-04 |
20090142253 | METHOD AND SYSTEM FOR PRODUCING ACTIVATED CARBON - An activated carbon producing system includes a heating furnace for thermally decomposing multi-layer film including a polyvinyl alcohol layer and cellulose triacetate (TAC) layers formed on surfaces of the polyvinyl alcohol layer, to produce carbonized material by carbonization. An activation device activates the carbonized material with heat, to produce activated carbon by forming fine pores therein. A burner assembly combusts acetic acid contained in pyrolysis gas created by thermal decomposition in the heating furnace, to produce gaseous carbon dioxide. A first heat exchanger exchanges heat between the pyrolysis gas from the burner assembly and heat exchange medium, to provide the heating furnace with the heat of the heat exchange medium. A washer absorbs gaseous carbon dioxide contained in the pyrolysis gas from the first heat exchanger by use of alkaline absorption solution. If the multi-layer film contains additive, the washer washes away the combusted additive. | 2009-06-04 |
20090142254 | Method of making mixed metal oxide catalysts for ammoxidation and/or oxidation of lower alkane hydrocarbons - The present invention comprises a method for preparing a mixed oxide catalyst for use in producing acrylonitrile or methacrylonitrile from propane or isobutene by ammoxidation in a gaseous phase via methods of heating or calcining precursor solid mixture to obtain mixed metal oxide catalyst compositions that exhibit catalytic activity. | 2009-06-04 |
20090142255 | LITHIUM-MANGANESE OXIDES, METHOD FOR PREPARING THE SAME, AND LITHIUM ADSORBENT USING THE SAME - There is provided Lithium-manganese oxides expressed as the following chemical formula 1, | 2009-06-04 |
20090142256 | METHOD FOR PRODUCING A NANOSTRUCTURED MATERIAL - A method capable of easily producing a nanostructured material having regular nanoscale arrangement. The method comprises a raw material solution preparation step of preparing a raw material solution by dissolving, in a solvent, a block copolymer comprising a polymer block component “A” and a polymer block component “B” which are immiscible to each other, and an inorganic precursor which coordinates with the polymer block component “A” but does not coordinate with the polymer block component “B”; and a nanostructure-forming step of forming a nanophase-separated structure “ | 2009-06-04 |
20090142257 | Inorganic hydrogen compounds and applications thereof - Compounds are provided comprising at least one neutral, positive, or negative hydrogen species having a binding energy greater than its corresponding ordinary hydrogen species, or greater than any hydrogen species for which the corresponding ordinary hydrogen species is unstable or is not observed. Compounds comprise at least one increased binding energy hydrogen species and at least one other atom, molecule, or ion other than an increased binding energy hydrogen species. One group of such compounds contains one or more increased binding energy hydrogen species selected from the group consisting of H | 2009-06-04 |
20090142258 | PHYSIOCHEMICAL PATHWAY TO REVERSIBLE HYDROGEN STORAGE - In one embodiment of the present disclosure, a process for cyclic dehydrogenation and rehydrogenation of hydrogen storage materials is provided. The process includes liberating hydrogen from a hydrogen storage material comprising hydrogen atoms chemically bonded to one or more elements to form a dehydrogenated material and contacting the dehydrogenated material with a solvent in the presence of hydrogen gas such that the solvent forms a reversible complex with rehydrogenated product of the dehydrogenated material wherein the dehydrogenated material is rehydrogenated to form a solid material containing hydrogen atoms chemically bonded to one or more elements. | 2009-06-04 |
20090142260 | IN VIVO DETECTION OF APOPTOSIS - The invention provides methods and products, such as kits, useful for determining the apoptotic state of cells in an organism, comprising detecting the presence or abundance of at least one caspase affinity labeling agent in the cells of an animal into which at least one caspase affinity labeling agent has been introduced, wherein the presence or abundance of the caspase affinity labeling agent correlates with the apoptotic state of the cells. | 2009-06-04 |
20090142261 | EPHB3-Specific Antibody and Uses Thereof - EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer. | 2009-06-04 |
20090142262 | Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer - The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer. | 2009-06-04 |
20090142263 | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 - The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, cytokines, interferons, target or reporter moieties and hematogenous cells. | 2009-06-04 |
20090142264 | 18F-Labeled Phenoxyphenyl Nu-benzyl Alkanamid Derivatives for Positron Emission Tomography (PET) Imaging of Peripheral Benzodiazepine Receptor - The present invention provides novel | 2009-06-04 |
20090142265 | ALPHA-FLUOROALKYL TETRABENAZINE AND DIHYDROTETRABENAZINE IMAGING AGENTS AND PROBES - The present invention provides novel alpha-fluoroalkyl compounds having structure I and the corresponding dihydrotetrabenazine compounds IV | 2009-06-04 |
20090142266 | PEPTIDES DERIVED FROM MAUROCALCINE USED AS VECTORS FOR INTRACELLULAR ADDRESSING OF MOLECULES OF INTEREST - Use of a peptide vector for intracellular addressing of a substance of interest, said vector essentially comprising a peptide which is derived from maurocalcine corresponding to the following sequence (I): Z-X | 2009-06-04 |
20090142267 | FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TANSMEMBRANE DRUG DELIVERY SYSTEMS - The present invention comprises a method for delivering pharmaceutical and/or imaging agents within and/or through the dermal, mucosal and other cellular membranes, and across the blood-brain barrier, utilizing a fusogenic protein. The fusogenic protein is associated with a phospholipid membrane, such as a liposome. The liposome may include dioleoylphosphatidylserine, a negatively charged long-chain lipid. Alternatively, the liposome is comprised of a mixture of negatively charged long-chain lipids, neutral long-chain lipids, and neutral short-chain lipids. Preferred fusogenic proteins include saposin C and other proteins, polypeptides and peptide analogs derived from saposin C. The active agent contained within the liposome may comprise biomolecules and/or organic molecules. This technology can be used for both cosmetic and medicinal applications in which the objective is delivery of the active agent within and/or beneath biological membranes or across the blood-brain barrier and neuronal membranes. | 2009-06-04 |
20090142268 | CHAIN-END FUNCTIONALIZED POLY(ETHYKENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME - There is provided a novel chain-end functionalized PEO of formulas (I) to (IV) prepared via living anionic polymerization and chain-end functionalization, as well as a simple method of preparing nano-sized transition metal or metal salt particles using the same, which can be readily stabilized even in an aqueous medium. The water-soluble PEO-based polymers having various functional groups (including a drug group such as vitamin and anti-cancer agent) and the process of preparing nano-sized transition metal or metal salt particles using the same can be advantageously used in the development of new materials for drug delivering system and imaging, e.g., a contrast agent and an anti-cancer agent simultaneously. | 2009-06-04 |
20090142269 | ISOTOYPICALLY-LABELED BENZOTHIAZOLE COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS - The present invention provides an isolated linezolid impurity, desfluoro linezolid, the preparation thereof and its use as a reference standard. | 2009-06-04 |
20090142270 | PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY - The invention provides improved agents and methods for treatment of cerebral amyloid angiopathy (CAA) and methods to effect prophylaxis of CAA. The methods can treat CAA concurrently with Alzheimer's disease or separately. The methods can effect prophylaxis of CAA concurrently with Alzheimer's disease or separately. The methods involve administering antibody that is specific for the N-terminus of Aβ or an agent that can induce such an antibody. | 2009-06-04 |
20090142271 | DENDRITIC CELLS - The present invention provides systems for isolating, characterizing, and modulating brain dendritic cells. The invention may allow a better understanding of and opportunities to modulate neurodevelopmental processes (such as, for example, neurogenesis) and neurological diseases (such as, for example, Alzheimer's Disease). | 2009-06-04 |
20090142272 | Pfks as modifiers of the igfr pathway and methods of use - Human PFK genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of PFK are provided. | 2009-06-04 |
20090142273 | Activatable cest MRI agent - A chemical exchange saturation transfer (CEST) contrast agent is provided. One embodiment includes a ligand and a functional group linked to the ligand. The functional group has a hydrogen exchange site and is capable of undergoing a change in chemical functionality by enzyme catalysis or reaction with a metabolite to change the chemical exchange rate or the MR frequency of the hydrogen exchange site. | 2009-06-04 |
20090142274 | Intracellular nanosensors and methods for their introduction into cells - The invention provides ion-selective sensors capable of selectively measuring ions, e.g., Na | 2009-06-04 |
20090142275 | Wound Suture Capable of Identifying the Presence of Bacteria - A wound suture containing a solvatochromatic indicator that undergoes a color change in the presence of bacteria often associated with surgical site infection is provided. Such a color change provides a “real time” indication of the onset of infection, which may alert medical staff to apply an appropriate antimicrobial treatment (e.g., antibiotic) to the patient (e.g., human or animal) before a more serious infection occurs. The patient may also be able to accurately monitor the condition of a wound after discharge from the hospital. Further, the lack of a color change may provide the medical staff or patient with the assurance that the area is generally free of infection and clean. | 2009-06-04 |
20090142276 | ALPHA-FLUOROALKYL DIHYDROTETRABENAZINE IMAGING AGENTS AND PROBES - The present invention provides novel alpha-fluoroalkyl dihydrotetrabenazine compounds I | 2009-06-04 |
20090142277 | TREATMENT OF ACTIVE INFECTIONS AND RELATED COMPOSITIONS - The present invention is directed to the treatment of infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue. More specifically, the present invention is directed to aerosols that are used to treat infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue, compositions from which the aerosols are generated and methods of generating the aerosols. In an aerosol aspect of the present invention, an aerosol for delivery to the sinus cavity of a patient is provided. The aerosol includes at least: a) one or more compounds selected from antibiotics, antifungals, leukotriene antagonists, anti-TNF compounds, antihistamines, steroidal antiinflammatories, mucolytics, estrogen, progesterone and related hormones; and, b) water The compounds are present in the water at a concentration ranging from 0.01 mg/kg to 1000 mg/kg, and the aerosol does not contain a surfactant. | 2009-06-04 |
20090142278 | Effervescent Compositions Comprising Phosphonates and Methods Related Thereto - The invention provides effervescent composition comprising a bisphosphonate, an acidic compound, an alkaline effervescing component, and optionally an anti-ulcer agent and methods of treating osteoporosis in a mammal using the effervescent compositions. | 2009-06-04 |
20090142279 | NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS - Muscarinic Acetylcholine receptor antagonists and methods of using them are provided. | 2009-06-04 |
20090142280 | Protective skin care peptides - The disclosed invention provides tetrapeptides with the amino acid sequence proline-glutamine-glutamate-X (P-Q-E-X), where X can be either lysine (K) or isoleucine (I). These tetrapeptides inhibit ultraviolet light (UV)-induced expression of the pro-inflammatory cytokine interleukin-6 (IL-6) by skin epithelial cells and fibroblasts. Furthermore, the tetrapeptides repress the upregulation of matrix metalloproteinase-1 (MMP-1) by skin fibroblasts induced by either direct exposure to UV rays or treatment with media conditioned by UV-treated keratinocytes. The small size and bio-activity of the tetrapeptides render them suitable for use in therapies directed to inflammatory skin disorders and as active ingredients in skin care products. | 2009-06-04 |
20090142281 | Composition Comprising A Coupled Enzyme System - The present invention relates to a composition comprising a coupled enzyme system for the rapid and efficient production of hydrogen peroxide by the coupling of a first enzyme system capable of hydrogen peroxide generation, to a second enzyme system which utilizes the non hydrogen peroxide product of the first enzyme system, and optionally is capable of generating further hydrogen peroxide. | 2009-06-04 |
20090142282 | High-solids alcoholic solutions of rosin esters for varnish applications - High-solids solutions of solid rosin esters and lower alcohols can be obtained at rosin ester concentrations above the binary solubility of the rosin ester in the alcohol. Such solutions can be achieved by adding an additional modified rosin or by dissolving a small amount of the alcohol in the rosin ester. These solutions are useful as varnishes for use on humans and animals, particularly when ethanol is the alcohol. The varnish may optionally contain a therapeutic agent. | 2009-06-04 |
20090142283 | PEPTIDE-BASED ANTIDANDRUFF REAGENTS - Peptide-based antidandruff reagents, formed by coupling a skin-binding peptide with an antidandruff agent, are described. The skin-binding peptide part of the peptide-based antidandruff reagent binds strongly to the skin, thus keeping the antidandruff agent coupled to the skin for a long lasting effect. Hair care compositions comprising the peptide-based antidandruff reagents are also provided as well as methods for treating or preventing dandruff. | 2009-06-04 |
20090142284 | Water-based olefin-graft polymer system for multifunctional cosmetic applications - A polymer emulsion for use in a cosmetic composition includes an olefin copolymer; a copolymer of an acidic monomer to include acrylic acid, methacrylic acid or other unsaturated, carboxyl containing monomer; optionally, at least one stabilizing emulsifier; optionally, a resin selected from a group consisting of an acrylic resin and styrene-acrylic resin, said resin having an average molecular weight from about 500 to about 15,000 daltons; and, optionally, a polymer selected from a group consisting of oxidized polyethylene polymers and oxidized polypropylene polymers, said polymer modified with cationic end-groups such as tallow alkyl amines. | 2009-06-04 |
20090142285 | COSMETIC COMPOSITION COMPRISING ASCORBIC ACID 2-GLUCOSIDE AND ERGOTHIONEINE - This invention relates to a cosmetic composition allowing the effects of skin aging to be reduced or delayed, comprising as the cosmetically active ingredients ascorbic acid 2-glucoside and ergothioneine. The invention also relates to the use of these cosmetically active ingredients in a cosmetic composition as agents to stimulate DNA repair enzymes, particularly enzymes to repair oxidised DNA bases in dermal and epidermal cells. Finally, the invention relates to a cosmetic treatment process involving this use. | 2009-06-04 |
20090142286 | Cosmetic Makeup And/Or Care Process - The present invention relates to a cosmetic process for making up and/or caring for keratin material(s), comprising the application, on contact with a keratin material, of at least one cosmetic composition comprising at least one fatty phase and consisting of at least 75% by weight, relative to its total weight, of compound(s) approved for food use. | 2009-06-04 |
20090142287 | EMULSIFIED ANTIPERSPIRANT COMPOSITION AND METHOD FOR MAKING SAME - Antiperspirant compositions that include a continuous phase employing a water-immiscible liquid and a structurant, and a disperse phase employing a solution of antiperspirant active in water. | 2009-06-04 |
20090142288 | Hair Straightening Composition Comprising a Disaccharide - A hair straightening composition comprising at least one hydroxide ion generator and a disaccharide. | 2009-06-04 |
20090142289 | COMPOSITION CONTAINING A HARD WAX AND A PASTY COMPOUND, AND PROCESS FOR THE CARE OR MAKING UP OF THE EYELASHES - Composition containing an aqueous phase, at least 10% by weight of at least one hard wax, relative to the total weight of the composition, and at least one pasty compound. Also described is a composition containing an aqueous phase, at least one hard wax, at least one pasty compound, and possibly at least one oil, the hard wax(es)/(pasty compound(s)+possible oil(s)) weight ratio ranging from 2 to 8. The uses thereof for the care or the making up of keratinous fibres and in particular the eyelashes are also described. | 2009-06-04 |
20090142290 | SHAVING GEL PRODUCTS - The present invention comprises a soap-free self-foaming shave gel composition which maintains superior performance attributes while avoiding the harshness and drying associated with soap-based shave preparations. The shave gel composition of the present invention comprises water, a short-chain polyol, a water-soluble sarcosinate salt, and a volatile self-foaming agent. | 2009-06-04 |
20090142291 | PIGMENTED COSMETIC AND PERSONAL CARE COMPOSITION AND PROCESS FOR PREPARING THE SAME - A pigment dispersed in a silicone polymer is combined with at least one cosmetic component or at least one dematologically acceptable and active agent to prepare a wide variety of cosmetic and personal care compositions. The pigment may be dispersed in a polysiloxane, such as an alkylpolysiloxane, to provide a pigment dispersion that is easily blended with cosmetically acceptable components or dematologically active agents to provide a pigmented cosmetic or personal care composition. | 2009-06-04 |
20090142292 | Method For The Mitigation of Symptoms of Dry Eye - A method for the mitigation of symptoms of dry eye is disclosed. The method involves at least (a) incorporating one or more non-functionalized polymers having one or more hydrophilic moieties into an ophthalmic device that is a polymerization product of a comonomer mixture comprising: (i) a major amount of a non-silicone-containing hydrophilic monomer; and (ii) an end terminal functionalized surfactant; and (b) inserting the ophthalmic device in the eye of a patient. | 2009-06-04 |
20090142293 | Polyammonium/Polysiloxane Copolymers - The invention relates to polyammonium/polysiloxane copolymers, methods for production and use thereof. | 2009-06-04 |
20090142294 | PARAMETER SELECTED GM-CSF, IL-3, IL-4, IL-5 AND CHIMERAS THEREOF FOR THERAPEUTIC AND DIAGNOSTIC PURPOSES - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the short chain 4 helix bundle superfamily such as GM-CSF, IL-3, IL-4 and IL-5 or chimeric molecules thereof comprising at least a portion of the protein molecule, such as GM-CSF-Fc, IL-3-Fc, IL-4-Fc and IL-5-Fc; wherein the protein or chimeric molecule thereof has a profile of measurable physiochemical parameters, wherein the profile is indicative of, associated with or forms the basis of one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 2009-06-04 |
20090142295 | Anti-Connexin Compounds and Uses Thereof - Methods and compositions for modulating the activities of connexins are provided, including, for example, for use for treatment of cardiovascular, vascular, neurological, for wounds and for other indications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication or prevention of hemichannel opening is desirable. | 2009-06-04 |
20090142296 | Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue - This invention provides a method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue in a subject comprising administering to the subject an amount of interleukin-8 effective to attract endothelial progenitor cells to the ischemia-damaged tissue. | 2009-06-04 |
20090142297 | 5-SUBSTITUTED ISOINDOLINE COMPOUNDS - This invention relates to 5-substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed. | 2009-06-04 |
20090142298 | Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C - The invention refers to medicine, in particular to hepatology and virology, and can be used for treatment, including complete recovery, of patients with viral hepatitis C, including its chronic form. This invention provides a remedy for treating viral hepatitis C, that is, apoprotein lactoferrin in a monomeric form. This invention also refers to a pharmaceutical composition for treating viral hepatitis C that contains a therapeutically effective amount of apoprotein lactoferrin in a monomeric form and a pharmaceutically acceptable vehicle, filler or excipient. This invention also refers to a pharmaceutical composition for treating viral hepatitis C that includes administration of apoprotein lactoferrin in a monomeric form and to using apoprotein lactoferrin in a monomeric form for manufacturing a medication for treating viral hepatitis C. The treatment method of this invention allows to prevent virus viremia completely as a result of two or three weeks treatment, to prevent destruction of hepatocytes, affected with hepatitis C virus, together with the emission of additional number of viruses to the blood circulation system and to end the existence of the affected with virus hepatocytes with apoptosis, thus, preventing the development of hepatosis, cirrhosis and oncological damage to the liver, being the terminal stage of the main disease development. | 2009-06-04 |
20090142299 | MACROCYCLIC TETRAZOLYL HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to compounds of Formula I, II, III or IV, or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 2009-06-04 |
20090142300 | Compositions and methods related to toll-like receptor-3 - The invention relates to compositions and methods related to Toll-like receptor (TLR) polypeptides. In some embodiments, the invention relates to managing TLR3 related diseases. In further embodiments, the invention relates to methods of preventing and treating inflammation. In some embodiments, the invention relates to antagonists of TLR3, to amino acid sequences that act as dominant negative molecules, and to nucleic acid sequences that encode said amino acid sequences. In additional embodiments, the invention relates to the manipulation of biological materials to evaluate TLR3 activity. | 2009-06-04 |
20090142301 | NOVEL PHARMACEUTICAL COMPOSITION OF INTERFERON GAMMA OR PIRFENIDONE WITH MOLECULAR DIAGNOSTICS FOR THE IMPROVED TREATMENT OF INTERSTITIAL LUNG DISEASES - The present invention relates to a novel pharmaceutical composition of compounds having the biological activity of interferon gamma (IFN-γ) or pirfenidone in combination with a diagnostic array of candidate polynucleotides for the improved treatment of all forms of interstitial lung disease, in particular of idiopathic pulmonary fibrosis (IPF). | 2009-06-04 |
20090142302 | INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 FOR TREATMENT OF CANCER - Methods of treating a tumor in a subject include identifying a subject having, at risk for, or suspected of having a tumor, and administering to the subject an effective amount of an IGFBP7 agent if the tumor has increased Ras-BRAF-MEK-Erk signaling, is dependent for growth and/or survival upon the Ras-BRAF-MEK-Erk signaling pathway, and/or expresses an activated or oncogenic BRAF or RAS. | 2009-06-04 |
20090142303 | METHODS AND COMPOSITIONS FOR DRIED CELLULAR FORMS - Methods and compositions of spray drying cellular material are provided that allow preservation of the cellular material. In one aspect, the cellular material is spray dried with a quantity of excipient. In another aspect, the cellular material is spray dried using a cryoprotectant. | 2009-06-04 |
20090142304 | Composition for Improving Intestinal Flora - A composition provided by the present invention for improving intestinal microflora includes 1-kestose as an active ingredient. The present invention further provides a lactic acid bacteria proliferating agent including 1-kestose as an active ingredient, which proliferates | 2009-06-04 |
20090142305 | PEGYLATED FIBRINOGEN-BASED BIOMATRIX - The invention involves methods and materials related to fibrin-based biomatrices. | 2009-06-04 |
20090142306 | METHODS AND SYSTEMS FOR TREATING ISCHEMIC TISSUES - Methods and systems for regenerating damaged tissue rely on direct injection of selected therapeutic cells into a tissue at or near the site of tissue damage. Direct injection is accomplished using an intravascular catheter having a deployable needle, and injection is usually targeted into the adventitial and peri-adventitial tissues surrounding the blood vessel from which the needle is deployed. | 2009-06-04 |